ArticleEuropean thyroid journal2022

Initial or salvage treatment with apatinib shows promise against radioiodine-refractory differentiated thyroid carcinoma.

Xian Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.